ANGLE (LON:AGL) Stock Rating Reaffirmed by Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of ANGLE (LON:AGL) in a research report released on Thursday, Marketbeat Ratings reports. They currently have a GBX 70 ($0.94) target price on the stock.

ANGLE Stock Performance

ANGLE stock opened at GBX 8.21 ($0.11) on Thursday. The company has a market cap of £26.49 million, a PE ratio of -117.34 and a beta of 0.22. The company has a fifty day moving average price of GBX 12.83 and a two-hundred day moving average price of GBX 14.49. The company has a debt-to-equity ratio of 17.22, a current ratio of 5.19 and a quick ratio of 6.18. ANGLE has a 12 month low of GBX 7.11 ($0.10) and a 12 month high of GBX 37.40 ($0.50).

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.